BNP Paribas Financial Markets
TENX icon

BNP Paribas Financial Markets’s Tenax Therapeutics TENX Stock Holding History

BNP Paribas Financial Markets’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$490K Buy
30,647
+15,351
+100% +$208K ﹤0.01% 3601
2025
Q4 		$186K Buy
+15,296
New +$133K ﹤0.01% 4086
2014
Q3 		– Hold
0
– -$33 – 4272
2014
Q2 		– Hold
0
– – – 3791
2014
Q1 		– Hold
0
– – – 3336
2013
Q4 		– Hold
0
– – – 4089

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets's TENX Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Tenax Therapeutics (TENX) stake by 100% in Q1 2026, buying an estimated $208K and bringing the position to 30,647 shares worth $490K. The position accounts for ﹤0.01% of the portfolio, ranked #3601.

BNP Paribas Financial Markets first reported a position in TENX in Q4 2025 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • BNP Paribas Financial Markets held 30,647 shares of Tenax Therapeutics worth $490K as of Q1 2026.
  • BNP Paribas Financial Markets bought 15,351 Tenax Therapeutics shares in Q1 2026, an estimated $208K.
  • Tenax Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #3601 holding.
  • BNP Paribas Financial Markets first reported a position in Tenax Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.